AI assistant
Sending…
Cytosorbents Corp — Director's Dealing 2017
Jun 6, 2017
34501_dirs_2017-06-06_27954c79-14d1-413f-a703-f7a3d55fdc4a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2017-06-06
Reporting Person: Mortensen Eric R. (Chief Medical Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 0 | Direct |
More from Cytosorbents Corp
Annual Report
2026
Apr 15
Delisting Announcement
2026
Apr 2
Annual Report
2026
Mar 30
Earnings Release
2026
Mar 25
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2025
Nov 21
Earnings Release
2025
Nov 13
Interim / Quarterly Report
2025
Nov 13
Delisting Announcement
2025
Oct 3
Regulatory Filings
2025
Sep 16